Company Search:
Advanced Search
Sponsored Links
Sonoma Pharmaceuticals Inc Company Snapshot
Sonoma Pharmaceuticals Inc operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sonoma Pharmaceuticals Inc with three other companies in this sector in the United States: Repro-Med Systems, Inc. (2017 sales of $12.29 million ), Encision Inc. ($8.87 million ), and Isoray, Inc. ($4.76 million of which 100% was Medical Devices).

Sales Analysis. During the year ended March of 2017, sales at Sonoma Pharmaceuticals Inc were $12.83 million. This is a decrease of 15.0% versus 2016, when the company's sales were $15.08 million. The sales level in 2017 was fairly close to the level five years ago: in 2012, Sonoma Pharmaceuticals Inc had sales of $12.74 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sonoma Pharmaceuticals Inc
  Stock Performance Chart for Sonoma Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 5.39
(Figures in U.S. Dollars)
1 Week 1.3%   13 Weeks 7.5%  
4 Weeks 15.4%   52 Weeks 4.6%  
Sonoma Pharmaceuticals Inc Key Data:
  Ticker: SNOA Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2017 Sales 12,825,000
(Year Ending Jan 2018).
Employees: 75
  Currency: U.S. Dollars Market Cap: 23,727,324
  Fiscal Yr Ends: March Shares Outstanding: 4,404,062
  Share Type: Common Closely Held Shares: 218,211
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.